Loading...
XSWXSKAN
Market cap1.89bUSD
Dec 20, Last price  
75.20CHF
1D
0.40%
1Q
-6.47%
IPO
-14.06%
Name

SKAN Group AG

Chart & Performance

D1W1MN
XSWX:SKAN chart
P/E
64.26
P/S
5.28
EPS
1.17
Div Yield, %
0.33%
Shrs. gr., 5y
16.90%
Rev. gr., 5y
156.99%
Revenues
320m
+15.55%
4,313,9013,100,9125,660,58920,266,61415,403,9151,947,8192,854,9883,757,504191,689,000234,265,000276,955,000320,020,000
Net income
26m
+38.59%
3,522,5052,244,1124,476,80218,449,54915,968,69215,200,6645,762,66717,955,28611,587,00021,398,00018,986,00026,312,000
CFO
9m
-85.85%
1,162,665690,794242,347-42,7391,338,854983,8962,269,4062,215,33022,634,00010,317,00061,483,0008,700,000
Dividend
May 10, 20240.35 CHF/sh

Profile

SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
IPO date
Apr 05, 2007
Employees
1,269
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
320,020
15.55%
276,955
18.22%
234,265
22.21%
Cost of revenue
268,118
107,617
92,865
Unusual Expense (Income)
NOPBT
51,902
169,338
141,400
NOPBT Margin
16.22%
61.14%
60.36%
Operating Taxes
4,891
3,796
3,328
Tax Rate
9.42%
2.24%
2.35%
NOPAT
47,011
165,542
138,072
Net income
26,312
38.59%
18,986
-11.27%
21,398
84.67%
Dividends
(5,621)
(5,396)
(10,617)
Dividend yield
0.31%
0.38%
0.95%
Proceeds from repurchase of equity
(880)
73,503
BB yield
0.06%
-6.56%
Debt
Debt current
870
1,608
1,095
Long-term debt
5,804
15,514
14,609
Deferred revenue
5,911
6,727
3,809
Other long-term liabilities
686
589
1,387
Net debt
(81,628)
(96,111)
(116,753)
Cash flow
Cash from operating activities
8,700
61,483
10,317
CAPEX
(35,298)
(28,865)
(42,607)
Cash from investing activities
(17,346)
(76,418)
(11,017)
Cash from financing activities
(15,801)
(4,846)
67,484
FCF
28,151
150,823
(53,355)
Balance
Cash
85,122
110,982
131,539
Long term investments
3,180
2,251
918
Excess cash
72,301
99,385
120,744
Stockholders' equity
59,079
165,595
174,006
Invested Capital
130,368
89,430
72,635
ROIC
42.78%
204.29%
277.85%
ROCE
26.84%
88.33%
72.41%
EV
Common stock shares outstanding
22,484
22,484
12,644
Price
80.80
28.25%
63.00
-28.89%
88.60
 
Market cap
1,816,669
28.25%
1,416,462
26.45%
1,120,220
 
EV
1,742,170
1,328,648
1,017,728
EBITDA
64,296
180,030
149,027
EV/EBITDA
27.10
7.38
6.83
Interest
464
132
Interest/NOPBT
0.27%
0.09%